-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Cognition Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q2 2024.
- Cognition Therapeutics Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$14.7M, a 24.2% decline year-over-year.
- Cognition Therapeutics Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$58.7M, a 37.5% decline year-over-year.
- Cognition Therapeutics Inc annual Operating Income (Loss) for 2023 was -$50.7M, a 16.5% decline from 2022.
- Cognition Therapeutics Inc annual Operating Income (Loss) for 2022 was -$43.6M, a 52.3% decline from 2021.
- Cognition Therapeutics Inc annual Operating Income (Loss) for 2021 was -$28.6M, a 64.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)